Clinuvel Pharmaceuticals | CUV - Biaya Operasional

Harga Saham

9.75

Perubahan Harian

-0.08 -0.81%

Bulanan

-11.52%

Tahunan

-16.02%

Q1 Perkiraan

9.72

Keuangan

AUD

AUD 231.12M

AUD 35.2M

Biaya Penjualan

AUD 1.93M

AUD 222.06M

Kewajiban Lancar

AUD 25.21M

AUD 879.78K

Dividen - Hasil

0.69

AUD 32.21M

AUD 27.55M

16

Eps Laba Per Saham

AUD 0.44

Modal Dan Cadangan

AUD 203.01M

Laba Kotor Pada Penjualan

AUD 57.82M

Beban Bunga Utang

AUD 2.43M

AUD 509.92K

Kapitalisasi Pasar

AUD 488.09M

Batas Pemasukan

AUD 24.7M

Biaya Operasional

AUD 20.71M

Laba Operasional

AUD 39.05M

Modal Saham Biasa

AUD 168.8M

Pe Harga Untuk Laba

14.46

Laba Sebelum Pajak

AUD 35.87M

Pendapatan Penjualan

AUD 55.92M

Beban Penjualan Dan Administrasi

AUD 9.12M

AUD 9.52M

Kreditur Perdagangan

AUD 2.79M

Debitur Perdagangan

AUD 26.24M

	Biaya Operasional	Perubahan		Tanggal
Avita Medical	AUD 28.02M		1.55M	2025-12
Medical Developments International	AUD 21.61M		11.59M	2025-12
Mesoblast	USD 56.15M		32.57M	2025-06
Neuren Pharmaceuticals	AUD 25.23M		16.54M	2025-12
Pacific Edge	NZD 25.34M		2.03M	2025-12
Paradigm Biopharmaceuticals	AUD 8.49M		2.13M	2025-06
PYC Therapeutics	AUD 33.63M		14.33M	2025-12
Telix Pharmaceuticals	AUD 405.4M		26.29M	2025-12